Sarah Walsh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sarah Walsh has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
D. Creamer
Department of Dermatology King’s College Hospital London UK
10 shared publications- Saskia Ingen-Housz-Oro
Dermatology Department, APHP Hôpital Henri Mondor APHP Créteil France
5 shared publications Pauline Meskell
School of Nursing and Midwifery, University of Limerick , Limerick
4 shared publications- Pauline O' Reilly
School of Nursing and Midwifery, University of Limerick , Limerick
4 shared publications Sheila Ryan
School of Nursing and Midwifery, University of Limerick , Limerick
4 shared publicationsAlice Coffey
School of Nursing and Midwifery, University of Limerick , Limerick
3 shared publications
Latest Publications
- 25 October 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (11) , 1752-1753
Predicting for severity in DRESS : When to speak to ICU
- 25 October 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (11) , 1752-1753
Predicting for severity in DRESS : When to speak to ICU
- 25 October 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (11) , 1746-1747
From prediction to prevention: Are we ready to intercept PsA before it begins?
- 25 October 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (11) , 1746-1747
From prediction to prevention: Are we ready to intercept PsA before it begins?
- Open Access
- 22 July 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (11) , 1756-1764
Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS / TEN
Background: Autoimmune bullous diseases ( AIBD ), Stevens‐Johnson syndrome and toxic epidermal necrolysis ( SJS ‐ TEN ) and erythema multiforme ( EM ) often present with clinically similar features in the oral mucosa: classically widespread mucosal erosions or ulceration. Despite this, there are no formalized guidelines for the specific management of the oral manifestations of these conditions. Objectives: We sought to establish an consensus on the management of oral involvement of AIBD , SJS ‐ TEN and EM using the Delphi method. Methods: Participants were sent a survey comprising 62 statements organized into 6 categories: general oral and dental recommendations; disease severity scoring; topical therapies for active oral involvement in AIBD; systemic therapies for active oral involvement in AIBD; additional considerations for inpatient care of AIBD, EM, SJS‐TEN; specific considerations for EM and SJS‐TEN. Participants rated the level of appropriateness of each statement. Results were analysed using the RAND/UCLA Appropriateness Method. Results: 34 experts, primarily Oral Medicine clinicians and Dermatologists, completed the survey. Consensus was achieved for 58 (93.5%) statements after a single round. General recommendations included rigorous oral hygiene and regular dental/periodontal care. Disease‐specific severity scoring was recommended to guide treatment and monitor response. For active oral AIBD, experts recommended moderate‐to‐super potent topical corticosteroids, guided by severity and site of oral disease. For inpatients, supported oral hygiene, regular topical anaesthetics and nutritional support for impaired intake were recommended. For acute EM and SJS‐TEN, recommendations included regular lip care with gentle debridement of haemorrhagic crusts and application of soft paraffin. Conclusions: This Delphi sets out a broad framework for the management of oral involvement in AIBD, SJS‐TEN and EM, to be adapted by a multidisciplinary team, for both acute and long‐term management of these conditions. It may help to standardize the management of oral manifestations of these conditions in future multicentre studies.
- 22 July 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (11) , 1756-1764
Open AccessExpert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS / TEN
Background: Autoimmune bullous diseases ( AIBD ), Stevens‐Johnson syndrome and toxic epidermal necrolysis ( SJS ‐ TEN ) and erythema multiforme ( EM ) often present with clinically similar features in the oral mucosa: classically widespread mucosal erosions or ulceration. Despite this, there are no formalized guidelines for the specific management of the oral manifestations of these conditions. Objectives: We sought to establish an consensus on the management of oral involvement of AIBD , SJS ‐ TEN and EM using the Delphi method. Methods: Participants were sent a survey comprising 62 statements organized into 6 categories: general oral and dental recommendations; disease severity scoring; topical therapies for active oral involvement in AIBD; systemic therapies for active oral involvement in AIBD; additional considerations for inpatient care of AIBD, EM, SJS‐TEN; specific considerations for EM and SJS‐TEN. Participants rated the level of appropriateness of each statement. Results were analysed using the RAND/UCLA Appropriateness Method. Results: 34 experts, primarily Oral Medicine clinicians and Dermatologists, completed the survey. Consensus was achieved for 58 (93.5%) statements after a single round. General recommendations included rigorous oral hygiene and regular dental/periodontal care. Disease‐specific severity scoring was recommended to guide treatment and monitor response. For active oral AIBD, experts recommended moderate‐to‐super potent topical corticosteroids, guided by severity and site of oral disease. For inpatients, supported oral hygiene, regular topical anaesthetics and nutritional support for impaired intake were recommended. For acute EM and SJS‐TEN, recommendations included regular lip care with gentle debridement of haemorrhagic crusts and application of soft paraffin. Conclusions: This Delphi sets out a broad framework for the management of oral involvement in AIBD, SJS‐TEN and EM, to be adapted by a multidisciplinary team, for both acute and long‐term management of these conditions. It may help to standardize the management of oral manifestations of these conditions in future multicentre studies.
- Open Access
- 3 February 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (5) , 968-970
Development of a health-related quality of life outcome measure for adults with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) – QoLTEN: an international multidisciplinary DELPHI consensus survey
The aim of this Delphi study was to establish an international multidisciplinary SJS/TEN expert group consensus on the items for inclusion in QoLTEN: a bespoke quality of life outcome measure for adults with SJS/TEN.
- 3 February 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (5) , 968-970
Open AccessDevelopment of a health-related quality of life outcome measure for adults with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) – QoLTEN: an international multidisciplinary DELPHI consensus survey
The aim of this Delphi study was to establish an international multidisciplinary SJS/TEN expert group consensus on the items for inclusion in QoLTEN: a bespoke quality of life outcome measure for adults with SJS/TEN.
- 28 December 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6)
A scoping review of case reports and small case series in Stevens–Johnson syndrome/toxic epidermal necrolysis
- 28 December 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6)
A scoping review of case reports and small case series in Stevens–Johnson syndrome/toxic epidermal necrolysis
- 23 December 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (1) , 15-16
What your patient is thinking: Lived experience narrative
- 23 December 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (1) , 15-16
What your patient is thinking: Lived experience narrative
- Open Access
- 21 June 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Impact of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on the health-related quality of life (HRQoL) experiences of adults with SJS/TEN: a mixed-methods systematic review
Background: People who have survived Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) live with many different long-term sequelae, with some clinicians referring to the importance of appreciating the chronic phase of SJS/TEN. Consequently, it is important to examine the health-related quality of life (HRQoL) impacts on patients’ lives, to enhance healthcare practitioners’ understanding of the long-term implications for this group of patients. Objectives: To synthesize the evidence related to the impact of SJS/TEN on the HRQoL experiences of adults with SJS/TEN. Methods: This review was guided by the Joanna Briggs Institute (JBI) approach to mixed-methods systematic reviews. Fifteen international databases were searched, including CINAHL Complete, MEDLINE (Ovid), MEDLINE (EBSCO), Embase, PsycINFO, Scopus, the Cochrane Library, Lenus, MedNar, PROSPERO, Portail Epidémiologie France, HAL-OAR, DUMAS, RIAN.ie and Lenus. No search limits were set on languages or year of publication. The end date of the search was November 2024. The initial search yielded a total of 6154 articles. Data extraction was performed for the final 26 included studies and synthesized following the JBI methodology for mixed-methods systematic reviews, using a convergent integrated approach. Results: Arising from the data synthesis process, three themes were constructed: (i) SJS/TEN physical sequelae and impact on quality of life (QoL) experiences; (ii) SJS/TEN psychological sequelae and impact on QoL experiences; and (iii) sociological impacts of SJS/TEN on QoL experiences. Conclusions: The findings will help clinicians consider the long-term effects of SJS/TEN on HRQoL in patients/those who have survived when planning acute and postdischarge care. This systematic review informed, in part, the development of a bespoke QoL outcome measure, namely QoLTEN. This is under pilot evaluation.
- 21 June 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Open AccessImpact of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on the health-related quality of life (HRQoL) experiences of adults with SJS/TEN: a mixed-methods systematic review
Background: People who have survived Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) live with many different long-term sequelae, with some clinicians referring to the importance of appreciating the chronic phase of SJS/TEN. Consequently, it is important to examine the health-related quality of life (HRQoL) impacts on patients’ lives, to enhance healthcare practitioners’ understanding of the long-term implications for this group of patients. Objectives: To synthesize the evidence related to the impact of SJS/TEN on the HRQoL experiences of adults with SJS/TEN. Methods: This review was guided by the Joanna Briggs Institute (JBI) approach to mixed-methods systematic reviews. Fifteen international databases were searched, including CINAHL Complete, MEDLINE (Ovid), MEDLINE (EBSCO), Embase, PsycINFO, Scopus, the Cochrane Library, Lenus, MedNar, PROSPERO, Portail Epidémiologie France, HAL-OAR, DUMAS, RIAN.ie and Lenus. No search limits were set on languages or year of publication. The end date of the search was November 2024. The initial search yielded a total of 6154 articles. Data extraction was performed for the final 26 included studies and synthesized following the JBI methodology for mixed-methods systematic reviews, using a convergent integrated approach. Results: Arising from the data synthesis process, three themes were constructed: (i) SJS/TEN physical sequelae and impact on quality of life (QoL) experiences; (ii) SJS/TEN psychological sequelae and impact on QoL experiences; and (iii) sociological impacts of SJS/TEN on QoL experiences. Conclusions: The findings will help clinicians consider the long-term effects of SJS/TEN on HRQoL in patients/those who have survived when planning acute and postdischarge care. This systematic review informed, in part, the development of a bespoke QoL outcome measure, namely QoLTEN. This is under pilot evaluation.
- 4 March 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (7) , 1209-1211
Regulating sunbed use: Skin cancer risks linked to tanning beds
- 4 March 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (7) , 1209-1211
Regulating sunbed use: Skin cancer risks linked to tanning beds
- 24 January 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (2) , 247-248
Images in Dermatology: Showcasing the best of dermatological imaging
- 24 January 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (2) , 247-248
Images in Dermatology: Showcasing the best of dermatological imaging
- 23 December 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (1) , 9-10
Private equity in dermatology: A cloud on the horizon of quality care?
- 23 December 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (1) , 9-10
Private equity in dermatology: A cloud on the horizon of quality care?